Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer.
Identifieur interne : 000112 ( PubMed/Corpus ); précédent : 000111; suivant : 000113Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer.
Auteurs : Madison Collins ; Cristina O'Donoghue ; Weihong Sun ; Jun-Min Zhou ; Zhenjun Ma ; Christine Laronga ; Marie Catherine LeeSource :
- The Journal of surgical research [ 1095-8673 ] ; 2017.
Abstract
Sentinel lymph node (SLN) biopsy is the current prognostic tool for clinically node-negative breast cancer patients. If the SLN reveals macrometastasis, axillary lymph node dissection (ALND) is recommended. However, the use of ALND in patients with micrometastasis is debated. The objective of this study was to assess the utilization of ALND in the treatment of micrometastatic breast cancer.
DOI: 10.1016/j.jss.2017.03.039
PubMed: 28688661
Links to Exploration step
pubmed:28688661Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer.</title><author><name sortKey="Collins, Madison" sort="Collins, Madison" uniqKey="Collins M" first="Madison" last="Collins">Madison Collins</name><affiliation><nlm:affiliation>University of South Florida Morsani College of Medicine, Tampa Florida.</nlm:affiliation></affiliation></author><author><name sortKey="O Donoghue, Cristina" sort="O Donoghue, Cristina" uniqKey="O Donoghue C" first="Cristina" last="O'Donoghue">Cristina O'Donoghue</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Sun, Weihong" sort="Sun, Weihong" uniqKey="Sun W" first="Weihong" last="Sun">Weihong Sun</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Zhou, Jun Min" sort="Zhou, Jun Min" uniqKey="Zhou J" first="Jun-Min" last="Zhou">Jun-Min Zhou</name><affiliation><nlm:affiliation>Department of Biostatistics, Moffitt Cancer Center and Research Institute Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Ma, Zhenjun" sort="Ma, Zhenjun" uniqKey="Ma Z" first="Zhenjun" last="Ma">Zhenjun Ma</name><affiliation><nlm:affiliation>Department of Biostatistics, Moffitt Cancer Center and Research Institute Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Laronga, Christine" sort="Laronga, Christine" uniqKey="Laronga C" first="Christine" last="Laronga">Christine Laronga</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Marie Catherine" sort="Lee, Marie Catherine" uniqKey="Lee M" first="Marie Catherine" last="Lee">Marie Catherine Lee</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida. Electronic address: M.Catherine.Lee@moffitt.org.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28688661</idno><idno type="pmid">28688661</idno><idno type="doi">10.1016/j.jss.2017.03.039</idno><idno type="wicri:Area/PubMed/Corpus">000112</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000112</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer.</title><author><name sortKey="Collins, Madison" sort="Collins, Madison" uniqKey="Collins M" first="Madison" last="Collins">Madison Collins</name><affiliation><nlm:affiliation>University of South Florida Morsani College of Medicine, Tampa Florida.</nlm:affiliation></affiliation></author><author><name sortKey="O Donoghue, Cristina" sort="O Donoghue, Cristina" uniqKey="O Donoghue C" first="Cristina" last="O'Donoghue">Cristina O'Donoghue</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Sun, Weihong" sort="Sun, Weihong" uniqKey="Sun W" first="Weihong" last="Sun">Weihong Sun</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Zhou, Jun Min" sort="Zhou, Jun Min" uniqKey="Zhou J" first="Jun-Min" last="Zhou">Jun-Min Zhou</name><affiliation><nlm:affiliation>Department of Biostatistics, Moffitt Cancer Center and Research Institute Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Ma, Zhenjun" sort="Ma, Zhenjun" uniqKey="Ma Z" first="Zhenjun" last="Ma">Zhenjun Ma</name><affiliation><nlm:affiliation>Department of Biostatistics, Moffitt Cancer Center and Research Institute Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Laronga, Christine" sort="Laronga, Christine" uniqKey="Laronga C" first="Christine" last="Laronga">Christine Laronga</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</nlm:affiliation></affiliation></author><author><name sortKey="Lee, Marie Catherine" sort="Lee, Marie Catherine" uniqKey="Lee M" first="Marie Catherine" last="Lee">Marie Catherine Lee</name><affiliation><nlm:affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida. Electronic address: M.Catherine.Lee@moffitt.org.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The Journal of surgical research</title><idno type="eISSN">1095-8673</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sentinel lymph node (SLN) biopsy is the current prognostic tool for clinically node-negative breast cancer patients. If the SLN reveals macrometastasis, axillary lymph node dissection (ALND) is recommended. However, the use of ALND in patients with micrometastasis is debated. The objective of this study was to assess the utilization of ALND in the treatment of micrometastatic breast cancer.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28688661</PMID><DateCreated><Year>2017</Year><Month>07</Month><Day>09</Day></DateCreated><DateRevised><Year>2017</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>215</Volume><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J. Surg. Res.</ISOAbbreviation></Journal><ArticleTitle>Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer.</ArticleTitle><Pagination><MedlinePgn>55-59</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(17)30165-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2017.03.039</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sentinel lymph node (SLN) biopsy is the current prognostic tool for clinically node-negative breast cancer patients. If the SLN reveals macrometastasis, axillary lymph node dissection (ALND) is recommended. However, the use of ALND in patients with micrometastasis is debated. The objective of this study was to assess the utilization of ALND in the treatment of micrometastatic breast cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">An IRB approved, retrospective study of a pooled dataset of breast cancer patients with micrometastatic disease on SLN biopsy was performed. Patients diagnosed from 1999-2016 were identified via query of a single-institution National Comprehensive Cancer Network (NCCN) breast cancer database as well as a prospective tumor board.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 91 patients were diagnosed with micrometastatic nodal disease. The median age at diagnosis was 56 y (range: 31-85); median follow-up time was 47 mo (range: 0-203 mo). 42/91(46.2%) patients had ALND of which 37/42 (88.1%) were a second operation; 3/42(7.1%) patients had additional positive nodes found at ALND. 44/91 (48.4%) patients received radiation. 7/91 (7.7%) patients had a recurrence, 5/7 local, including one axillary (2.1%; patient declined ALND).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Given that the risk of lymphedema after ALND ranges between 20%-53%, the morbidity of ALND may far exceed the likelihood of detecting further nodal involvement in women with micrometastatic disease: 7.1% in this series.</AbstractText><CopyrightInformation>Copyright © 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Madison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of South Florida Morsani College of Medicine, Tampa Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donoghue</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Weihong</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jun-Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Moffitt Cancer Center and Research Institute Tampa, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Zhenjun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Moffitt Cancer Center and Research Institute Tampa, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laronga</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Marie Catherine</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Comprehensive Breast Program, Moffitt Cancer Center, Tampa, Florida; Department of Surgery, University of South Florida, Tampa, Florida. Electronic address: M.Catherine.Lee@moffitt.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Axillary lymph node dissection</Keyword><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword><Keyword MajorTopicYN="N">Micrometastasis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>02</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28688661</ArticleId><ArticleId IdType="pii">S0022-4804(17)30165-8</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2017.03.039</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000112 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000112 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28688661
|texte= Use of axillary lymph node dissection (ALND) in patients with micrometastatic breast cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28688661" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |